Human papillomaviruses (HPVs) may be grouped according to the site from which they are isolated and the disease with which they are associated. We recently identified and cloned HPV type 51 (HPV-51) from a low-grade precancerous lesion (G. Nuovo, E. DeVilliers, R. Levine, S. Silverstein, and C. Crum. J. Virol. 62:1452-1455, 1988). Molecular epidemiologic analysis of cervical lesions, including condylomata and low-and high-grade precancers, revealed that HPV-51 was present in about 5% of the samples we examined. We have now determined the complete nucleotide sequence of this virus and compared it with other sequenced HPVs. Our analysis reveals that the 7,808-bp genome is composed of eight open reading frames which are encoded on the same strand and that this virus is most closely related to HPV-31. Sequence comparisons place this virus in the group of high-risk viruses (those with an increased risk of progressing to malignancy) along with (13) . The best criteria for the classification of novel isolates are direct DNA sequence analysis and comparison of the amino acid coding potential of novel isolates with known oncogenic and benign strains. Members of this virus family are the causative agents for a variety of benign lesions that result from abnormal epithelial cell differentiation, and HPVs are frequently subgrouped according to their association with cutaneous or mucosal sites. Some of these viruses are associated with genital neoplasias which range in severity from mild dysplasia to frank carcinoma (7, 24, 27, 38, 70, 71) . The ability of specific virus early gene products to interact with host proteins such as p53 and RB105 (25, 43, 54, 66) may be the molecular basis that differentiates viruses with the ability to cause malignant disease from those which cause benign papillomas.
Human papillomaviruses (HPVs) are small icosahedral viruses that contain a double-stranded DNA genome of approximately 8 kbp. The genomes of more than 60 independent HPVs have been isolated as molecular clones. A new isolate is designated a novel strain if it is .50% homologous to any other known HPV as determined by liquid hybridization analysis (13) . The best criteria for the classification of novel isolates are direct DNA sequence analysis and comparison of the amino acid coding potential of novel isolates with known oncogenic and benign strains. Members of this virus family are the causative agents for a variety of benign lesions that result from abnormal epithelial cell differentiation, and HPVs are frequently subgrouped according to their association with cutaneous or mucosal sites. Some of these viruses are associated with genital neoplasias which range in severity from mild dysplasia to frank carcinoma (7, 24, 27, 38, 70, 71) . The ability of specific virus early gene products to interact with host proteins such as p53 and RB105 (25, 43, 54, 66) may be the molecular basis that differentiates viruses with the ability to cause malignant disease from those which cause benign papillomas.
We previously used Southern blot hybridization, in a molecular epidemiologic study, to correlate HPVs with their segregation patterns according to the pathology of the lesions at genital sites (18) . In this study several HPV DNAs with novel restriction endonuclease digestion profiles were detected. One of these DNAs, originally identified in a condyloma as an -8 kbp HindIII fragment, was cloned and used to screen a panel of virus DNAs. Molecular hybridization analysis revealed that this DNA genome represented a novel isolate which was designated HPV type 51 (HPV-51) (47) The prevalence of HPV-51 in a small sampling of biopsies derived from patients with abnormal Papanicolaou smears was examined, and it was shown to be present in 7 of 127 samples derived from patients with condylomata, cervical intraepithelial neoplasia, or carcinoma. A more recent prevalence study using polymerase chain reaction (PCR) * Corresponding author.
analysis suggested that this virus was present in a percentage (-3%) of the population similar to that of other virus types (e.g., HPV-6, -16, -18, -31, and -33) which were more frequently associated with genital lesions (4) .
We have determined the complete nucleotide sequence of HPV-51 and compared the arrangement and homologies of its open reading frames (ORFs) with those of other genital isolates. Transfection of HPV-51 DNA into either the BALB 3T3 or the CREF rodent fibroblast cell line results in morphological transformation of these cells. The HPV-51-transformed lines express RNAs that have the potential to encode the E6 and E7 oncoproteins.
MATERIALS AND METHODS
Cloning and sequence analysis. The HPV-51 genome as described in Nuovo et al (47) was excised from vector DNA by digestion with HindIII, and the 7.6-kb virus band was purified from a 0.5% agarose gel by solubilizing the gel and binding the DNA to glass powder (64) . The DNA was cleaved with PstI, and the three PstI and the two HindIllPstI fragments were subcloned into M13mpl8 and -19. Nucleotide sequence was determined by the dideoxy chain terminator method (53) both manually and by using an Applied Biosystems automated DNA sequencer. Where necessary the length of the insert was pared with exonuclease III, and the family of nested deletions that resulted was sequenced. In several instances oligonucleotides that flanked regions for which no sequence information was available were prepared and used to determine the intervening sequence. Sequences were compiled and analyzed by using a commercially available sequence analysis package, DNASIS, from LKB.
The 232-bp HindIII fragment which encodes the E6 ORF was cloned after amplification of DNA isolated from two biopsies containing TAGGCAGTTG CCCTCCTTAT CTTCATCTAT GTCTTCATCT  5301  TATGCAAATG TTACTATTCC ATTTTCAACT ACATATTCTG TTCCTATTCA TACAGGGCCT GATGTGGTAT TGCCCACATC TCCTACAGTA TGGCCTTATG  5401  TTCCCCACAC TTCCATTGAC ACCAAGCATT CTATTGTTAT ACTAGGTGGG GATTACTATT TGTGGCCCTA TACACATTTA CTACGCAAAC GCCGTAAACG   5501  TATACCCTAT TTTTTTACAG ATGGCATTGT GGCGCACTAA TGACAGCAAG GTGTATTTGC CACCTGCACC TGTGTCTCGA ATTGTGAATA CAGAAGAATA  5601  TATCACACGC ACCGGCATAT ATTACTATGC AGGCAGTTCC AGACTAATAA CATTAGGACA TCCCTATTTT CCAATACCTA AAACCTCAAC GCGTGCTGCT   5701   ATTCCTAAAG TATCTGCATT TCAATACAGG GTATTTAGGG TACAGTTACC AGATCCTAAC AAGTTTGGAC TCCCGGATCC AAATTTATAT AATCCAGACA  5801  CAGATAGGTT GGTGTGGGGT TGTGTGGGCG TTGAGGTGGG CAGAGGACAG CCCCTTGGTG TTGGCCTTAG TGGTCATCCC TTATTTAATA AATATGATGA   5901  CACAGAAAAT TCACGCATAG CAAATGGCAA TGCACAACAA GATGTTAGAG ATAACACATC TGTTGACAAC AAACAGACTC AGTTATGTAT AATAGGCTGT   6001   GCTCCACCTA TTGGGGAACA CTGGGGTATT GGCACTACAT GCAAAAACAC ACCTGTACCT CCAGGAGACT GCCCCCCCCT GGAACTTGTA TCCTCTGTCA   6101   TTCAGGATGG CGATATGATT GATACAGGGT TTGGAGCTAT GGATTTCGCT GCCCTACAGG CCACCAAATC AGACGTCCCT TTGGATATTT CACAGTCTGT  6201  TTGTAAATAT CCTGATTATT TAAAAATGTC TGCAGACACA TATGGTAATT CCATGTTTTT TCATTTACGC AGGGAGCAAA TCTTTGCTAG GCACTATTAT  6301   AATAAACTTG TAGGTGTTGG GGAAGACATT CCTAACGATT ATTATATTAA GGGTAGTGGT AATGGCCGTG ACCCTATAGA AAGTTATATA TACTCTGCTA   6401  CTCCCAGTGG GTCTATGATA ACATCTGATT CTCAAATTTT TAATAAGCCT TATTGGCTCC ACCGTGCGCA GGGTCACAAT AATGGCATTT GCTGGAACAA  6501  TCAGCTTTTT ATTACCTGTG TTGATACTAC CAGAAGTACA AATTTAACTA TTAGCACTGC CACTGCTGCG GTTTCCCCAA CATTTACTCC AAGTAACTTT  6601  AAGCAATATA TTAGGCATGG GGAAGAGTAT GAATTGCAAT TTATTTTTCA ATTATGTAAA ATTACTTTAA CTACAGAGGT AATGGCTTAT TTACACACAA   6701   TGGATCCTAC CATTCTTGAA CAGTGGAATT TTGGATTAAC ATTACCTCCG TCTGCTAGTT TGGAGGATGC ATATAGGTTT GTTAGAAATG CAGCTACTAG   6801   CTGTCAAAAG GACACCCCTC CACAGGCTAA GCCAGATCCT TTGGCCAAAT ATAAATTTTG GGATGTTGAT TTAAAGGAAC GATTTTCTTT AGATTTAGAC   6901  CAATTTGCAT TGGGTCGCAA GTTTTTGTTG CAGGTTGGCG TACAACGCAA GCCCAGACCA GGCCTTAAAC GCCCGGCCTC ATCGGCATCC TCTTCCTCTT  7001  CCTCTTCAGC CAAACGTAAA CGTGTTAAAA AGTAATGTAT GTTAGTTTTT GTATGCTTGT GCACACTGTT GTATGCCTGT ATGTATATGT TTGTGTATGT  7101  ACTGTATGTG TTTTTGTGTG TGTGTGTGTT GTTGTTCCTG TATGTATGAG TTATGTATGT TTATTATTAA TAAACTATGT GGTGTGTGTG TGTGTGTTTT  7201  TGCATGACTG CATTTGTATG ACATGTACGG GTGTATGTGG GTATTACATT ATCCCCGTAG GTCAAGGGTG GTGTTTCGGT GGCGTCCCTA TTGCCCTACC   7301  CATTTTTTGC AGCACAACAG TTTATATTTG TGCTATTTAG TTATACTTTG TAGCTTCCAT TTTGTTACAG CTGCAGCCAT TTTGAGTGCA ACCGATTTCG   7401  GTTCGTGTAC TTTTAGTATA TTTGCCAAGT TTTAAACCAC AACTGCCAGT TGTTTTTGGC ATAAACCATC ATTTTTTTAT GACATAGTGC ATACATCCGC  7501  CCGCCCACGC CTTGTACTTG GCGCGCCTTA CCGGCGCTAG TCATACAACC TATTAGTCAT TTGTACTTTA ACAATTGTTG GCACACTGTT TTCCGCCCTA  7601  TAATAATTTA ACTGCTTATA GGCATGTATT TTTTGGCATA TTTTATCTTA CTAATTGCAT AGTTGGCAGG TCAAATACTA TGTTTTTAGT GCCAAGTTTC   7701  TATCCTACTT ATAAACCATC TTACTCATAT GCAGGTGTGC TACACAAATG TGTTACCTAA CCGATTTGTG TTCTGCCTAT GCTTGCAACA a Sequences were aligned and compared by using the Needleman-Wunsch algorithm (46) as implemented by the DNASIS analysis package running on an MS-DOS-based computer. NA, nucleic acid homology; AA, predicted amino acid homology within the ORF. Complete ORFs were used for comparison of the nucleic acids, and ORFs beginning with the first in-frame ATG codon were used for the amino acids, except for the E4 of HPV-16, -31, and -33 and the E5 of HPV-16 and -51, which have no in-frame ATG; in these instances the complete ORFs were used. Only the E4A ORF of HPV-6 and the 3' El ORF of HPV-16 were used for comparison.
endonuclease map of the original Hindlll fragment was prepared and each of the PstI-PstI and PstI-HindIII fragments was subcloned in both orientations in M13 vectors. These subclones were subjected to sequence analysis as described in Materials and Methods. Where the ability to read the sequence was exceeded by the length of the clone, that piece of DNA was subcloned or pared with exonuclease III, or specific oligonucleotide primers were synthesized and used to "walk" through the sequence. The sequencing strategy and clones analyzed are displayed in Fig. 1 The complete nucleotide sequence of the HPV-51 genome is shown in Fig. 2 . The first nucleotide was assigned on the basis of homology with HPV-16 DNA. The G+C content of this DNA is 39%. Alignment of the nucleotide sequence of HPV-51 with that of the other HPVs for which complete sequence information was available revealed that HPV-51 most closely resembled HPV-31 (Table 1) .
ORFs. The pattern of ORFs was determined and shown to be conserved with other sequenced HPVs. All of the ORFs, with the exception of that encoding the E5 homolog, contain an initiating methionine (Tables 1 and 2 ). A schematic representation of the major ORFs is shown in Fig. 1 (14) . Cole and Danos (14) proposed that the periodicity of these repeats and the presence of other highly conserved amino acids at regularly spaced intervals suggest that E6 has arisen as a result of a duplication event. In addition to the motifs they describe we note that, among the high-risk types (HPV-16, -18, -31, -33 and -51), there are additional highly conserved blocks of amino acids at invariant distances from the metal-binding domains ( (14) . Highly conserved amino acids previously noted by these authors are in boldface. Those conserved amino acids which were detected in this more extensive analysis, which included HPV-31 and -51, are underlined.
The El ORF is the largest found in papillomaviruses, and it encodes a protein which has been shown to dock to the virus-specified E2 DNA-binding protein when it interacts with sequences in the upstream regulatory region (URR) (6, 40) . Phylogenetic analysis of this ORF in human viruses suggests that it may be composed of two domains (14) . The El ORF in HPV-51 has the potential to encode a protein of 634 amino acids. There is considerable conservation of sequence homology at both the nucleotide and amino acid levels between the HPV-51 El ORF and other members of the HPV family (Table 1) .
E2 is a dimeric DNA-binding protein which recognizes the sequence ACCN6GGT (1, 41) and has both activator and repressor functions on the URR from bovine papillomavirus (BPV). These functions can be attributed to the presence of two functional domains which are separated by a spacer whose length is associated with the virus subgroup from which it is derived. Thus, viruses associated with epidermodysplasia verruciformis contain longer and more hydrophilic spacers than those associated with infections of the genital tract (36) . The N-and C-terminal segments encode the transactivation and repressor-dimerization domains, respectively. Repressor may be independently derived by transcription from an internal promoter in cells infected with BPV (62, 68) or by alternative splicing as detected in transcriptional analyses of cells and biopsy samples containing HPV-6, -11, or -16 (11, 22, 52) . In the genital papillomaviruses E2 binds to two sites that are proximal to transcriptional elements of the E6 promoter and represses transcription (5, 51, 63) . The E2 ORF of HPV-51 can encode a 358-amino-acid protein that has the characteristic threedomain structure of other papillomaviruses (28) . The 185-amino-acid N-terminal domain is rich in arginine and lysine residues and terminates at a conserved V-185. The 70-aminoacid C-terminal domain which begins at G-289 is preceded by a 104-amino-acid spacer. The relatively short size of the middle segment and the paucity of arginic and lysinic residues distinguish this virus from those associated with epidermodysplasia verruciformis (36) .
In HPVs the mRNA encoding the E4 ORF is most likely derived by splicing from a donor in El to an acceptor in E4 (11, 12, 45) , because the bulk of El RNA, as detected by in situ hybridization analysis, is found in the nucleus in cervical intraepithelial neoplasms (19) . The spliced mRNA can encode a functional E4 gene product, and immunohistochemical analysis of warts containing HPV-1 and early neoplasias containing HPV-16 reveals that E4 is expressed principally as a cytoplasmic protein in cells that stain positive for Li (16, 20, 21) . The E4 ORF in HPV-51 is completely contained within E2, as it is in other HPVs. Just upstream of the E4 ORF, at position 3270, is a potential splice acceptor which could be used to generate this species from any of several potential donor sites within the El ORF. Demonstration of this spliced species will require the analysis of mRNAs expressed in lesions containing HPV-51 or cell lines expressing the virus genome.
The E5 ORF from BPV has been studied in great detail. This 44-amino-acid protein is present in transformed cells as a membrane-associated homodimer (55) . The protein contains a hydrophobic core and a hydrophilic carboxyl-terminal tail which defines a single functional domain that is responsible for its ability to induce focus formation and stimulate cellular DNA synthesis (33, 59) . Recently, this protein was shown to activate the endogenous P-type receptor for the platelet-derived growth factor in transformed cells (48) . Although no clear function has been ascribed to the E5 ORFs in HPVs, the ESa ORF of HPV-6c was shown to transform 3T3 cells (10) . The ES ORF in HPV-51 lacks an initiator methionine and can encode a protein of 84 amino acids with a predicted molecular weight of 9,764. As in the other HPV ES ORFs there is a conserved Cys-X-Cys in the amino-terminal third of the protein, and there are three hydrophobic domains which have been suggested to constitute a membrane spanning region (8) .
The L2 and Li ORFs which encode the minor and major capsid proteins, respectively, are the products of late gene expression and are highly conserved between HPVs (Table  1) . They are typically only expressed in well-differentiated epithelium in the apical portion of a lesion (17, 44) . This sequence conservation has formed the basis for the development of a sensitive PCR assay which uses primers that specifically amplify the Li ORF for the detection and typing of HPV genomes (37 (Fig. 3B) . The shorter amplification product can be eliminated if the annealing temperature is raised to 550C. The Li ORF in HPV-51 can encode a 504-amino-acid protein which is approximately 80% homologous at the amino acid level to Lls from other HPVs. The L2 ORF consists of 468 amino acids and contains the motif T-T-P-A-V-L at position 148 along with clusters of basic residues at the amino and carboxy termini (56) ; the carboxy terminus overlaps the amino terminus of Li by 6 amino acids. The T-T-P-A-V-L motif is highly conserved among the mucosal HPVs, and its presence further cements the classification of this virus among these members of the HPV family (32) .
Regulatory motifs in the HPV-51 genome. Sequence motifs for interaction with known transcription factors were as described in Mitchell and Tjian (39) . b +, motifs that are in the sense orientation; -, motifs in the antisense orientation.
There are additional copies of this sequence throughout the genome; only the site in URR is shown here. d The GRE consensus used was from Chan et al. (9) . e HPV-16 GRE. f HPV-39 GRE (65).
to bind (1, 41) . These sequences are located at nucleotides 7391, 30, and 46 within URR, and a fourth copy of this sequence motif is found at position 4497 within L2. A mobility shift gel electrophoresis assay with end-labeled fragments from the HPV-51 URR (that contained the canonical E2 binding site sequence) was used to demonstrate that recombinant E2 from BPV would bind and alter the electrophoretic mobility of those fragments which contained these sites (data not shown).
Nucleotide sequence analysis of the HPV-51 URR reveals the presence of the many tightly clustered and overlapping regulatory elements; there is a homolog of the GRE, and there are seven copies of the NFI binding motif. In addition, there are single sites for AP1, Oct-1, Spl, and TFIID. The orientation and location of these sites is summarized in Table  4 . In addition to the single GRE in URR there are four other homologs of this sequence, three of which are clustered near the E5 ORF and one which is in L2.
Poly(A) signals for mRNA termination are bipartite, consisting of a signal AATAAA followed at a distance of 20 to 30 nucleotides by a GT-rich sequence (50) . Sequences homologous to this termination signal are found in all HPVs. In HPV-51 there are six copies of the AATAAA motif, and two of these, located at 4104 and 7169, are downstream of the early and late genes, respectively, and contain both components of the polyadenylation signal.
Finally, we note the occurrence of a decameric sequence that is composed of alternating G T residues which is repeated four times in the virus genome.
Transforming activity of HPV-51 DNA. Cloned DNAs from those HPVs which are associated with lesions that have a high risk for malignant progression have the capacity to transform rodent cells in culture (69) and to immortalize human keratinocytes (23, 35, 49 HPV-6, HPV-11, or placental DNA gave rise to no transformed colonies, whereas transfection with similar amounts of src DNA resulted in >500 CFU/ptg. Comparison of the morphologic transformation frequency of these same DNAs on BALB 3T3 cells resulted in too few transformants with either HPV-18 or HPV-51 DNAs to quantitate. A typical morphologically transformed CREF colony is shown in Fig.  4 . Several transformants were isolated and recloned twice. The cloned colonies were then expanded and examined for the presence of sequences homologous to HPV-51 DNA by PCR amplification of the E6, E7, and Li regions of this virus. The transformed cells contained amplification products of the appropriate size ( Fig. 5A and B) . Analysis of these products by digestion with restriction endonucleases demonstrated that they were derived from HPV-51 DNA (data not shown).
The state of virus DNA in a single PCR-positive clone was examined by Southern blot hybridization. Hybridization of transformed-cell DNA cleaved with Hincll (which should not cleave integrated virus DNA because the site is destroyed after release of the insert from the vector) revealed the presence of a single 14-kb species; after digestion with EcoRV (a single cutter), two bands were detected (data not shown). This result suggests that only a single copy of virus DNA was integrated into the genome of the transformed cell. Because products of both E6 and E7 are required for complete morphologic transformation (3, 30, 31, 34, 42) , we next examined the RNAs present in a line of transformed cells that were homologous to virus sequences from these regions of the HPV-51 chromosome. RNA isolated from the single-copy transformant was reverse transcribed with a primer (RT primer) that is downstream of the E7 termination codon (Fig. SB) . The resulting cDNAs were then amplified with primers that flank these ORFs and examined by gel electrophoresis. The electrophoretic mobilities of the products are shown in Fig. 5A 
